ELLE:PA:PA-Lyxor Global Gender Equality (DR) UCITS ETF - C-USD EUR (EUR)

ETF | Others |

Last Closing

USD 14.294

Change

+0.06 (+0.44)%

Market Cap

N/A

Volume

138.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.45 (-1.01%)

USD 56.03B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+4.40 (+0.93%)

USD 13.60B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+3.02 (+0.89%)

USD 11.29B
WRD:PA HSBC MSCI World UCITS ETF

+0.27 (+0.85%)

USD 11.04B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+1.26 (+0.52%)

USD 10.45B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+6.00 (+1.49%)

USD 8.68B
WLD:PA Lyxor UCITS MSCI World D-EUR

+2.32 (+0.75%)

USD 7.49B
HHH:PA HSBC S&P 500 UCITS ETF

+0.44 (+0.91%)

USD 7.22B
HSTE:PA HSBC ETFS PLC - HSBC Hang Seng..

-0.05 (-0.77%)

USD 6.16B
SPY4:PA SSgA SPDR S&P 400 US Mid Cap

+0.35 (+0.46%)

USD 5.38B

ETFs Containing ELLE:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -5.82% 37% F 39% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.82% 37% F 38% F
Trailing 12 Months  
Capital Gain 2.92% 40% F 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.92% 35% F 53% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 8.42% 53% F 62% D
Dividend Return 8.42% 54% F 59% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.76% 69% C- 91% A-
Risk Adjusted Return 96.13% 76% C+ 85% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike